today Pacific Dental Conference Mar. 17

exhibitors 16 Pacific Dental Conference — March 17, 2016 Univet Optical Technologies and Patterson Dental bring inovative glasses to Canada n GOCCLES (Glasses for Oral Cancer–CuringLightExposed–Screen- ing) — an innovative pair of glasses used for early screening of precancer- ous lesions in the oral cavity — are now available in Canada, a territory that the companies behind the device call “one of the world’s most demanding andevolvedoral-health-caremarkets.” ItaliancompanyPierrelPharmaSrl., developers of GOCCLES, announced thatUnivetOpticalTechnologies,licen- see of GOCCLES, working through the Toronto office of Univet Optical Tecnologies North America, signed the distribution agreement with North American distributor Patterson Dental Canada Inc. Patterson will have a sole right to GOCCLES distribution across all of Canada. A public company listed on the Nasdaq stock exchange, Patterson has focused on the sale and distri- bution of consumables and medical devices in the dental sector since its founding in 1878. Pierrel Pharma CEO Fabio Velotti said, “The agreement in Canada is an important milestone in the path of presentation, distribution and certifi- cation of our medical device across the world. Patterson is one of our long- standingpartners,withourcompanies already sharing a strong cooperation in the distribution of ORABLOC. With Univet, not only are we selling a good product, but above all, we are commit- ted to improving prevention — and pro- moting a culture of good health care. “North America is particularly aware of the risks connected to the human and economic costs of oral cancer. Can- ada, specifically, has been the first to understand the potential of GOCCLES, appreciating the science and the ease of use for a quick screening — a screen- ing that also is safe and non-inva- sive.” Velotti said that the registration process for GOCCLES in Canada had involved different regulations than those encountered with the device in the United States — with Canada being more similar to the European regula- tions. Paolo Portesi, CEO of Univet Group, licensee of GOCCLES, expressed satis- factionwiththeagreementwithPatter- son, describing the market as having the highest potential in the world: “It’s a contract that was created thanks to the strategic partnership with Pier- rel Pharma, which is already deeply seated in the North American market through ties with all of the major play- ers of the dental sector. “Furthermore the contract com- plements our global marketing and promotion policy, specifically with GOCCLES. I believe that our branch office of Toronto, Univet OTNA, is the best ambassador to show our care for the customers, our real-time service and our dedicated technical support. “In Italy and in the world, apart from North America, the oral cavity pathologies have received only partial and scarce attention. Univet and Pier- rel Pharma are committed to reducing such lack of knowledge by supporting actions to improve awareness.” Portesi said one way the compan- ies would work to increase scientific knowledge of the pathology of the oral cavity would be through participation in the months ahead at many of the world’s major dental meetings. Univet North America CEO Atif Sar- fraz said, “We are truly excited about ourpartnershipwithPatterson.Weare fully committed to give our very best to this relationship. Patterson is one of themostrespecteddistributionhouses in Canada; this agreement is going to extend our geographic reach and help usinourmissionofcreatingawareness abouttheimportanceofearlydetection Oral-cancer-screenng glasses catch on of oral cancer — and improving subse- quent increased survival rates.” Patterson’s National Marketing Director Alain Dumais said, “Patter- son Dental is one of North America’s largest, full-service dental distribu- tors. Key drivers are growing equip- ment-lines and technology-categories that are benefiting from the ongoing trend to digitize dentistry. Inclusion of GOCCLES demonstratively comple- ment our portfolio, and we have great planstosupportthedevicethroughour highly skilled field organization.” (Source: Patterson Dental)  GOCCLES work with common curing lights as a simple, non-invasive, test of the oral cavity for early screening of oral cancer and other precancerous lesions. (Photo/ Provided by Patterson Dental) Here at the PDC GOCCLEScanbeseenintheExhibitHallat the Patterson Dental booth (No. 419) and at the Univet Optical Tecnologies North Amer- ica booth (No. 1531).  As one of the most trusted names in pediatric esthetic restorations, NuSmile never fails to find new solu- tions for pediatric restorative dent- istry, according to the company. “After investigating the science and consult- ing with numerous pediatric dentists, it was clear that a complete solution was needed for preformed zirconia crowns for children,” said Diane John- son Krueger, NuSmile CEO. Thefirstthingthecompanydidwas develop a patent-pending process for manufacturingitsNuSmileZRzirconia crowns,whichdeliverexceptionalaes- thetics, durability and quality, accord- ing to the company. But NuSmile was also determined to tackle an even bigger challenge: Alandmark study1 had concluded that blood and saliva contamination to zir- conia occurs during intraoral trial fitting.Thiscontaminationisprovento significantly impair cement-to-crown retention,andsimplyrinsingthezirco- nia crown with water, isopropanol or even phosphoric acid after trial fitting is ineffective. NuSmile resolved it would solve the problems caused by saliva and blood contamination, and also eliminate any extra cleaning steps needed to remove this contamination — problems that other manufacturers were ignoring. NuSmile’s unique solution: Each of its pre-formed NuSmile ZR pedi- atric crowns comes with a matching reusable, autoclavable, pink Try-In crown. The Try-In crown is identical in size and shape to the actual zirconia crown, eliminating the need to place the actual crown in the mouth prior to cementation,thuscompletelyavoiding saliva/blood contamination. “Our Try- In crowns mean that the first time a NuSmile ZR zirconia crown enters the patient’s mouth is also the last time,” said Krueger, “and this means that contamination is impossible. No other zirconiacrowncompanycanmakethis promise.” These unique Try-In crowns are includedinNuSmileZRzirconiacrown kits at no additional charge. Toprovideitscustomersa“one-stop” complete zirconia solution, NuSmile also offers BioCem® Universal Bio- Active Cement (soon to be available in Canada) as well as burs recommended fortoothpreparationandcrownadjust- ment. NuSmile’s focus on preventing sal- iva contamination by offering a com- plete zirconia system appears to be NuSmile’s zirconia pediatric crown system prevents contamination, saves chair time well-founded. Independent research commissioned by the company indi- cates 80 percent of pediatric zirconia crown users consider it important to prevent saliva contamination, while 83 percent are interested in a complete system that includes zirconia crowns, Try-In crowns, cement and burs. “It is clear that dental professionals want a one-stop solution for all their needs involving pre-formed zirconia pediatric crowns, including the ability to prevent saliva contamination,” said Krueger. “That’s exactly what we’ve giventhem,andwecouldn’tbehappier with their response to the NuSmile ZR and Try-In crown system.” Reference 1. Kern et al., Influence of saliva contamina- tion on zirconia ceramic bonding. Dental Materials 24, 508-513 (2008). Here at the PDC Visit NuSmile in the Exhibit Hall in booth No. 1402. By NuSmile Staff

today Pacific Dental Conference Mar. 17

Pages Overview